A detailed history of Crossvault Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Crossvault Capital Management LLC holds 88,555 shares of ABBV stock, worth $15.7 Million. This represents 5.34% of its overall portfolio holdings.

Number of Shares
88,555
Previous 92,843 4.62%
Holding current value
$15.7 Million
Previous $15.1 Million 9.89%
% of portfolio
5.34%
Previous 4.85%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$137.62 - $174.96 $590,114 - $750,228
-4,288 Reduced 4.62%
88,555 $13.6 Million
Q1 2022

May 05, 2022

BUY
$131.98 - $163.75 $50,152 - $62,225
380 Added 0.41%
92,843 $15.1 Million
Q4 2021

Feb 07, 2022

BUY
$107.43 - $135.93 $300,589 - $380,332
2,798 Added 3.12%
92,463 $12.5 Million
Q3 2021

Nov 09, 2021

BUY
$106.4 - $120.78 $1.51 Million - $1.71 Million
14,175 Added 18.78%
89,665 $9.67 Million
Q2 2021

Aug 12, 2021

BUY
$105.21 - $117.21 $486,911 - $542,447
4,628 Added 6.53%
75,490 $8.78 Million
Q1 2021

Apr 28, 2021

BUY
$102.3 - $112.62 $69,052 - $76,018
675 Added 0.96%
70,862 $7.67 Million
Q4 2020

Feb 08, 2021

BUY
$80.49 - $108.67 $256,924 - $346,874
3,192 Added 4.76%
70,187 $7.52 Million
Q3 2020

Oct 21, 2020

BUY
$85.91 - $100.83 $321,561 - $377,406
3,743 Added 5.92%
66,995 $5.87 Million
Q2 2020

Aug 05, 2020

BUY
$73.37 - $98.18 $414,907 - $555,207
5,655 Added 9.82%
63,252 $6.21 Million
Q1 2020

Apr 17, 2020

BUY
$64.5 - $97.79 $1.21 Million - $1.83 Million
18,705 Added 48.09%
57,597 $4.39 Million
Q4 2019

Jan 31, 2020

BUY
$72.13 - $90.25 $1.68 Million - $2.1 Million
23,260 Added 148.8%
38,892 $3.44 Million
Q4 2018

Jan 30, 2019

BUY
$77.85 - $96.01 $404,819 - $499,252
5,200 Added 49.85%
15,632 $1.44 Million
Q1 2018

Apr 25, 2018

SELL
$92.01 - $123.21 $87,409 - $117,049
-950 Reduced 8.35%
10,432 $987,000
Q3 2017

Oct 30, 2017

BUY
$69.85 - $89.22 $795,032 - $1.02 Million
11,382
11,382 $1.01 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Crossvault Capital Management LLC Portfolio

Follow Crossvault Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossvault Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crossvault Capital Management LLC with notifications on news.